Health
OXGENE launches a scalable, plasmid-free manufacturing system for AAV – News-Medical.net
OXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-free manufacturing system for AAV.
OXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-free manufacturing system for AAV. OXGENE’s new TESSA™ technology addresses industry-wide challenges associated with robust and reproducible AAV manufacture at scale. These include high cost of goods, and low packaging efficiency. TESSA aims to deliver a paradigm shift in scalable AAV manufacture.
Adeno-associated virus, or AAV, is a popular choic…
-
General17 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General20 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News19 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business17 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher